Form 4: Syros Pharmaceuticals Executive Gerald Quirk Reports Stock Transactions
SEC Form 4 Filing
Gerald Quirk, Chief Legal & Compliance Officer of Syros Pharmaceuticals, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On March 27, 2024, Gerald Quirk, the Chief Legal & Compliance Officer of Syros Pharmaceuticals, had 22,500 restricted stock units vest, resulting in the acquisition of 22,500 shares of common stock.
- Following this transaction, Quirk directly held 46,803 shares of common stock.
- On March 28, 2024, 7,046 shares were disposed of to cover tax withholding obligations at a price of $5.59 per share.
- After this transaction, Quirk directly held 39,757 shares of common stock.
- The restricted stock units were granted on October 11, 2022, and vested in two tranches: 50% on October 11, 2023, and the remaining 50% on March 27, 2024.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by an executive, with no inherent positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Key Dates
| Date | Description |
|---|---|
| October 11, 2022 | Date of grant for the restricted stock unit award. |
| October 11, 2023 | First vesting date for 50% of the restricted stock units. |
| March 27, 2024 | Date of restricted stock unit vesting and acquisition of common stock. |
| March 28, 2024 | Date of stock disposal for tax withholding. |
| April 02, 2024 | Date of Form 4 filing. |
Keywords
Syros Pharmaceuticals, Gerald Quirk, Stock Transactions, Restricted Stock Units, Form 4, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.